Elago, Theodora V.
HRN: 06-68-59 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2024
CEFTRIAXONE 1G (VIAL)
03/27/2024
04/03/2024
IV
2g
Q24h
Empiric
Checking Final Appropriateness
03/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/27/2024
04/03/2024
IV
500mg
Q8
Empiric
Checking Final Appropriateness
03/28/2024
CEFUROXIME 1.5GM (VIAL)
03/28/2024
04/04/2024
IV
1.5g
Q8
Empiric
Checking Final Appropriateness